How Has The Size And Value Of The Genomic And Proteomic Tool Market Changed During The 2026–2030 Period?
The genomic and proteomic tool market size has grown rapidly in recent years. It will grow from $33.14 billion in 2025 to $37 billion in 2026 at a compound annual growth rate (CAGR) of 11.7%. The growth in the historic period can be attributed to rising genomic research funding, expansion of NGS technologies, growth in pharmaceutical R&D, increasing academic research activities, declining sequencing costs.
The genomic and proteomic tool market size is expected to see rapid growth in the next few years. It will grow to $56.95 billion in 2030 at a compound annual growth rate (CAGR) of 11.4%. The growth in the forecast period can be attributed to growth of precision medicine, increasing clinical genomics adoption, rising demand for proteomics in drug discovery, expansion of personalized diagnostics, advancements in bioinformatics tools. Major trends in the forecast period include high-throughput sequencing adoption, integrated multi-omics platforms, automation in sample preparation, growth of cloud-based bioinformatics, expansion of biomarker discovery.
Claim Your Free Report Sample Today:
What Drivers Are Contributing To The Expansion Trajectory Of The Genomic And Proteomic Tool Market?
The increasing adoption of personalized medicine is expected to propel the growth of the genomic and proteomic tool market going forward. Personalized medicine is the tailoring of prevention, diagnosis, and treatment to an individual’s molecular profile using biomarkers derived from deoxyribonucleic acid (DNA), ribonucleic acid (RNA), and proteins. The increasing adoption of personalized medicine is due to advances in genomics, proteomics, and biomarker discovery, which enable tailored treatments based on individual genetic profiles, driving demand for targeted therapies, improved diagnostics, and precision healthcare solutions. Advances in genomics, proteomics, and biomarker discovery have enabled the development of targeted therapies and more accurate diagnostics based on a patient’s genetic profile. Genomic and proteomic tools play a crucial role in this process by identifying genetic variations and protein biomarkers, allowing clinicians to optimize treatments and improve patient outcomes. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based nonprofit organization, the USFDA approved 16 new personalized treatments for rare disease patients in 2023, a significant increase from 6 personalized treatments in 2022. Therefore, the increasing adoption of personalized medicine is driving the genomic and proteomic tool market.
Which Primary Segments Are Included In The Detailed Analysis Of The Genomic And Proteomic Tool Market?
The genomic and proteomic tool market covered in this report is segmented –
1) By Product Type: Instruments, Consumables, Software, Services
2) By Technology: Sequencing, Microarray, Polymerase Chain Reaction (PCR), Mass Spectrometry, Electrophoresis, Chromatography
3) By Workflow Stage: Sample Preparation, Library Preparation, Data Analysis, Reporting
4) By Application: Drug Discovery, Diagnostics, Personalized Medicine, Agriculture And Animal Research
5) By End User: Academic And Research Institutions, Pharmaceutical And Biotechnology Companies, Diagnostic Laboratories, Healthcare Providers
Subsegments:
1) By Instruments: DNA Sequencing Systems, Polymerase Chain Reaction (PCR) Systems, Microarray Analyzers, Mass Spectrometry Instruments, Electrophoresis Systems, Chromatography Instruments, Flow Cytometers
2) By Consumables: Reagents And Kits, Assay Kits, Sample Preparation Consumables, Sequencing Consumables, Protein Assay Reagents, Microarray Chips, Laboratory Chemicals
3) By Software: Genomic Data Analysis Software, Proteomic Data Analysis Software, Bioinformatics Platforms, Clinical Data Interpretation Tools, Workflow Management Software, Cloud-based Analysis Platforms
4) By Services: Next-Generation Sequencing (NGS) Services, Gene Expression And Genotyping Services, Protein Identification And Quantification Services, Biomarker Discovery Services, Structural Biology Analysis Services, Bioinformatics And Data Interpretation Services, Molecular Diagnostics Services
What Trends Are Projected To Impact The Genomic And Proteomic Tool Market In The Coming Years?
Major companies operating in the genomic and proteomic tools market are focusing on innovation through spatial multi-omics technologies, which enable same-cell, in-situ detection of RNA and proteins to integrate molecular data layers, preserve tissue architecture, and accelerate discovery. Spatial multi-omics involves measuring gene expression and protein markers simultaneously within intact tissue at single-cell or subcellular resolution, offering richer biological insights than single-modality assays. For instance, in August 2025, 10x Genomics, a U.S.-based biotechnology company, introduced Xenium Protein, a first-of-its-kind assay for single-cell RNA and protein analysis on the Xenium in situ platform. This solution delivers a seamless, single-instrument workflow eliminating the need for cross-platform data integration and comes with validated, ready-to-use protein subpanels to simplify setup and quality control. These advancements allow researchers to maintain spatial context while expanding biomarker panels for applications such as target validation, patient stratification, and mechanism-of-action studies.
Which Major Corporations Play A Crucial Role In The Genomic And Proteomic Tool Market Landscape?
Major companies operating in the genomic and proteomic tool market are F. HoffmannLa Roche, Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Becton Dickinson and Company, GE Healthcare, Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc., Bruker Corporation, Waters Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V., PerkinElmer Inc., Promega, Novogene Corp., Oxford Nanopore Technologies Ltd., Pacific Biosciences of California Inc., Sophia Genetics, LC Sciences
Get Your In-Depth Genomic And Proteomic Tool Market Report Now:
Which Regions Demonstrate The Highest Growth Momentum In The Genomic And Proteomic Tool Market?
North America was the largest region in the genomic and proteomic tool market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the genomic and proteomic tool market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Contact Us:
The Business Research Company: Market Research Reports
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: info@tbrc.info
Follow Us On:
LinkedIn: The Business Research Company | LinkedIn
Comments
Post a Comment